Kenvue: B of A Securities maintains a 'Buy' Rating, The Target Price is $25

AinvestTuesday, Jul 15, 2025 12:00 pm ET
1min read

B of A Securities maintains 'Buy' rating on Kenvue(KVUE).

The target price is $25, compare with $27 previously.

[Recent Rating]

DateAgencyChangeRatingRating (previously)Target PriceTarget Price(previously)
2025-07-15B of A SecuritiesMaintainsBuyBuy$25$27
2025-07-15BarclaysMaintainsEqual-WeightEqual-Weight$22$23
2025-07-15CitigroupMaintainsNeutralNeutral$22$24.5

[Company Profile] Kenvue Inc. was incorporated in Delaware on February 23, 2022. The company is the world’s largest pure-play consumer health company. The company seek to deliver sustainable profitable growth through delivering science-backed innovative products, solutions and experiences centered around consumer health. With a presence in more than 165 countries worldwide and an over 135-year legacy, they are a global leader at the intersection of healthcare and consumer goods.

Sign up for free to continue reading

Unlimited access to AInvest.com and the AInvest app
Follow and interact with analysts and investors
Receive subscriber-only content and newsletters

By continuing, I agree to the
Market Data Terms of Service and Privacy Statement

Already have an account?

Comments



Add a public comment...
No comments

No comments yet